US$ 27.28
gip vs glp 1 receptor agonist Potential Use of GLP-1 and GIP/GLP-1 Agonists for Respiratory Disorders: Where Are We at? Targeting GLP-1, GIP & GCG
Description
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
Whether you're focusing on weight loss, appetite control, or feeling bet

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

Researchers are exploring whether semaglutide drugs like Ozempic and Wegovy could help prevent cognitive decline

In this paper we will explore the current state of play, suggest a possible future path for global sugar consumption and highlight ways companies can adapt so they can benefit from GLP-1 receptor agonists disruption.